Global Optical Genome Mapping Market size was valued at USD 104.9 Million in 2023 and is expected to reach USD 329.2 Million by 2032, at a CAGR of 17.5% during the forecast period 2023 – 2032.
Optical Genome Mapping Market: Overview
Optical genome mapping is a genomic technique that yields a high-resolution, long-range image of an organism’s genome. It allows for the investigation and mapping of structural variants such as massive deletions, insertions, duplications of gene inversions, and translocations across whole chromosomes.
There is a rising need for high-resolution, long-range genome mapping methods to supplement the use of next-generation sequencing (NGS) techniques, which allow for the complete investigation of structural variants and complicated genomic rearrangements.
Second, advances in optical mapping technologies, such as increased throughput, lower prices, and more accuracy, are broadening their use in a variety of scientific and clinical applications, such as cancer genomics, rare illness diagnostics, and agricultural genomics.
Third, growing investment in R&D by major market participants, as well as increased partnerships among academic institutions and industrial partners, are hastening technical developments and driving market expansion.
Furthermore, the use of optical genome mapping in precision healthcare efforts and the advent of innovative uses, such as microbiome analysis and epigenetic research, are fueling market expansion, placing optical genome mapping as a vital tool in genomics.
By product, services & software segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. Key trends in the services & software optical genome mapping market include the use of cloud-based data analysis solutions, rising demand for personalized service packages, and the incorporation of AI-driven algorithms to improve data interpretation.
By application, the structural variation detection segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. Structural variation detection trends in the Optical Genome Mapping market include developments in software algorithms, higher resolution capabilities, and combining complementary sequencing technologies for full genomic analysis.
By end user, the biotechnology & pharmaceutical companies, segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. Biotechnology and pharmaceutical firms are progressively incorporating optical genome mapping into precision medicine, drug development, and testing, leveraging its ability to detect structural differences and improve genomic analysis.
In North America, the optical genome mapping market is experiencing trends such as increased use of high-throughput genome analysis, increasing demand for precision medicine, and increased cancer genomics research.
Bionano’s is the only analytic program that receives and analyzes data from optical genome mapping (OGM), next-generation sequencing (NGS), and microarrays to contextualize all types of genomic variation and produce useful insights.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 104.9 Million |
| Projected Market Size in 2032 | USD 329.2 Million |
| Market Size in 2022 | USD 94.5 Million |
| CAGR Growth Rate | 17.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
CMI has comprehensively analyzed the Global Optical Genome Mapping market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict depth scenarios of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this Global Optical Genome Mapping industry.
The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.
List of the prominent players in the Optical Genome Mapping Market:
- Bionano Genomics
- Illumina Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Zymo Research Corp.
- Bio-Rad Laboratories Inc.
- PerkinElmer Inc.
- Roche Diagnostics
- 10X Genomics
- Bionano Genomics
- NanoString Technologies Inc.
- GenapSys Inc.
- Cytoscan Technologies Inc.
- Danaher Corporation
- Qiagen N.V.
- BGI Genomics Co. Ltd.
- Caris Life Sciences
- Exact Sciences Corporation
- Others
The Optical Genome Mapping Market is segmented as follows:
By Product
- Consumables
- Services & Software
- Instrument
By Application          Â
- Genome Assembly
- Structural Variation Detection
- Microbial Strain Typing
- Haplotype Phasing
- Others
By End User
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutions
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America